Article
Gene Therapy to Modulate Alpha-Synuclein in Synucleinopathies
4 Jun 2021
Abstract excerpt
The protein alpha-Synuclein (α-Syn) is a key contributor to the etiology of Parkinson's disease (PD) with aggregation, trans-neuronal spread, and/or depletion of α-Syn being viewed as crucial events in the molecular processes that result in neurodegeneration. The exact succession of pathological occurrences that lead to neuronal death are still largely unknown and are likely to be multifactorial in nature....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
